HSD17B13-IN-20
HSD17B13-IN-38 (Compound 18.02) is an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) . HSD17B13-IN-38 can be used in the research of liver diseases such as hepatitis, liver fibrosis, liver cirrhosis, and hepatocellular carcinoma[1].
Product Specifications
CAS Number
[2919797-59-2]
UNSPSC
12352005
Target
17β-HSD
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/hsd17b13-in-20.html
Solubility
10 mM in DMSO
Smiles
CCC[C@@H]1CN(CCN1C2=NC3=C(C(C4=CC(C(F)(F)F)=C(C(O)=C4F)F)=NN3C)C=N2)S(C)(=O)=O
Molecular Formula
C21H23F5N6O3S
Molecular Weight
534.50
References & Citations
[1]Johnny Y. Nagasawa, et al. Hsd17b13 inhibitors and uses thereof. WIPO, WO2023043836A1. 2023-03-23.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ALG8 (Probable Dolichyl Pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase, Asparagine-linked Glycosylation Protein 8 Homolog, Dol-P-Glc:Glc(1)Man(9)GlcNAc(2)-PP-dolichyl alpha-1,3-glucosyltransferase, Dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl G
ALG8 (Probable Dolichyl Pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase, Asparagine-linked Glycosylation Protein 8 Homolog, Dol-P-Glc:Glc(1)Man(9)GlcNAc(2)-PP-dolichyl alpha-1,3-glucosyltransferase, Dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl G
EOMES (Eomesodermin Homolog (Xenopus laevis), TBR2) (MaxLight 750)
EOMES (Eomesodermin Homolog (Xenopus laevis), TBR2) (MaxLight 750)